1. A. Lommen, R. Schilt, J. Weseman, A.H. Roos, J.W. van Velde, M.W. Nielen, J. Pharm. Biomed. Anal. 28 (2002) 87–96.
2. K. Vanoosthuyze, E. Daeseleire, A. Van Overbeke, C. Van Peteghem, Ermens, Analyst 119 (1994) 2655–2658.
3. K. De Wasch, H. De Brabander, D. Courtheyn, C. Van Peteghem,123 (1998) 2415–2422.
4. J. Sabbe, T.V. Beken (Eds.), BUFALAW-2001. European Commission, Falcone Programme, Maklu, Antwerpen-Apeldoorn, BE-NL. ISBN 9062156215803X, 2002, p. 226.
5. Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having hormonal or thyrostatic action and of beta-agonists and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EC. Off. J. Europ. Commun. 1996, L125, 3